news
New digital filter aims to improve chemical measurements
A filter has been designed to create more exact measurements early in the drug development stage and help move a drug to clinical trials faster.
List view / Grid view
Big Data
whitepaper
Whitepaper: Big Data in pharmaceuticals – big opportunities or big challenges or both?
Big data covers every facet of our working life. Every aspect of pharmaceutical research and development involves the generation of huge quantities of data, with the expectation that we can turn this information rapidly into useful knowledge, which in turn can be used to make ‘data-driven’ decisions to better understand…
news
Big Data and AI provide better diagnosis and treatment
MedUni Vienna researchers have developed a way to use retinal imaging to diagnose diabetes, explaining how the technique could be used for other conditions...
news
Top current pharmaceutical outsourcing trends
Most pharmaceutical companies are now outsourcing work to smaller firms, and here, European Pharmaceutical Review looks at current trends...
news
Holistic approach to data management for pharmaceutical manufacturers
PharmaIntegrity makes it quick and easy to identify and trend cleanroom contamination problems before they occur...
news
Russian Institute for Drugs and Good Practices unveils new data guide
Improving data integrity is the aim of a new guide published by the Russian State Institute for Drugs and Good Practices in collaboration with consultancy PQE Group...
news
Public trust in use of Big Data for health science ‘is vital’: researchers
Maintaining public confidence in the use of Big Data for health research is essential, according to international researchers.
news
Pharmacovigilance of new drugs ‘should be more proactive’ in New Zealand
The pharmacovigilance of new drugs and drug formulations undertaken in New Zealand should be proactive, says a leading expert.
article
Non-mutagenic impurities: more guidance needed on safety-based limits
More guidance is needed on the appropriate control of non-mutagenic impurities during clinical development, explains Dave P Elder, JPAG Member and pharmaceutical industry consultant, in this audio interview.
news
The future of water is clear – MECO ushers in a more efficient and environmentally friendly future for water purification
Taking advantage of technology developed in recent years, MECO announces smartANALYTICS® as a means of connecting its water purification machines and systems with big data analytics and in house expertise...
news
Machine learning may reveal cause-effect relationships in protein dynamics data
A group of researchers is showing how artificial intelligence approaches can help identify cause-effect relationships within data...
article
Issue #2 2018 – Digital Version
In this issue; recent developments in turning promising compounds into drug candidates, reviewing the latest trends in pharmaceutical microbiology and their implications, and a roundtable debate featuring the views of five industry leaders.
whitepaper
Application Note: Applying QbD in Process and Impurity Control Strategy Development
Global regulatory authorities continue to push Quality-by-Design (QbD) on pharmaceutical groups and their supporting corporate informatics infrastructure...
news
Online tool provides 3-D view of human metabolic processes
An international team of researchers has developed a computational resource that provides a 3D view of genes, proteins and metabolites involved in human metabolism...
news
The bioprocess platform software eve® is now compatible with Applikon and Sartorius bioreactors
Bottmingen, The latest version of eve® can integrate with a wide range of third-party bioreactors and equipment from a number of different suppliers, e.g. Sartorius DCU, Applikon or Matlab...
